Networking technology company Ethernity Networks (LON: ENET) completed a $1.3m contract with a US defence customer and continued to generate product enhancement revenues during 2025. There has been $200,000 recognised this year and up to $1m more could be generated. There could also be an additional licence agreement with the customer. The share price recovered 22.2% to 0.0033p.
Telematics services provider Quartix (LON: QTX) increased annualised recurring revenues by 14% to £37m by the end of 2025. Pre-tax profit was one-third higher at £8.7m and the dividend has been raised from 4.5p/share to 10p/share. The comparatives have been restated following a change in recognising costs. A pre-tax profit of £10.1m is forecast for 2026. The share price increased 15.1% to 244p.
Electrical connectors and accessories supplier Volex (LON: VLX) is continuing its strong momentum thanks to data centre investment enabling the doubling of revenues in this sub-sector. Volex was able to supply clients when other companies had supply issues. Other sectors are trading at similar levels to the previous year. Investec has increased its full year pre-tax profit forecast to $93.4m. Volex is considering a move back to the Main Market from AIM. It made the switch in 2018 when market capitalisation was £72.4m and it has increased to around twelve times that level. The share price, up 8.18% to 469.5p, is nearly back to the level in 2021.
Ian McDonough, executive chair of video editing software developer Blackbird (LON: BIRD), has bought 2.56 million shares at 1.932p each, taking his stake to 3.26%. The share price is 7.89% higher at 2.05p.
FALLERS
Chemotherapy drugs delivery developer CRISM Therapeutics (LON: CRTX) says US-based contract manufacturer ProMed Pharma has manufactured the first clinical batch of ChemoSeed and this will be used in the phase 2 clinical trial of irinotecan-ChemoSeed in glioblastoma. The share price slipped 13.7% to 11p.
Seascape Energy Asia (LON: SEA) has raised £4.2m at 70p/share, while a retail offer could raise up to £840,000. The oil and gas explorer and producer will invest the cash in its assets in Malaysia, including securing a farm-out for the Temaris PSC. There is production potential of more than 20,000 barrels of oil equivalent per day by 2028. The share price declined 8.23% to 72.5p.
FORGENT (LON: FORG), formerly Eqtec, has implemented savings that will halve recurring operating costs compared with the 2024 financial year. The share price is 1.49% lower at 0.033p.
Synthetic binders developer Aptamer (LON: APTA) is raising up to £3.75m via a placing and retail offer at 0.6p/share. The cash will be used for developing an in vivo liver fibrosis delivery vehicle, building an AI‑enabled Optimer® discovery engine focused on undeliverable and undruggable targets and extending manufacturing capacity. In the six months to December 2025, revenues rose 27% to £828,000 and there was a cash outflow from operations of £1.21m. Cash was £1.5m at the end of 2025. The share price fell 3.85% to 0.625p.